loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
he described the failure to send the patient for a ct scan on her hip as another "missed opportunity".
.
more stories from investigations
.
our partners
.
.
.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
.
.
.
"we realized early that this therapy had worked," corinna said of the sweat tests that doctors conducted after her twins, linus and maarten, were born.
.
.
.